052-5633265
הפרעת קשב?!
ילדות דיגיטלית

|

|

gmail
052-5633265
ילדות דיגיטלית
הפרעת קשב?!
ילדות דיגיטלית

פרק 6: האם הפרעת קשב היא פגם נוירו-ביולוגי?

רשימת מקורות

  1. ADDitude Editors, Silver L. The Neuroscience of the ADHD Brain: Truths about the ADHD brain that most people don’t understand.: ADDitude: Inside the ADHD mind, Last retreived on November 16, 2021, from: https://www.additudemag.com/neuroscience-of-adhd-brain/; 2021.
  2. Frontline Interview with Russell Barkley. Interview Russell Barkley. Frontline | PBS (Public Broadcasting Service). Last Retrieved on November 16, 2021 from: https://www.pbs.org/wgbh/pages/frontline/shows/medicating/interviews/barkley.html; Retrieved on November 2021.
  3. CHADD. The Science of ADHD. CHADD:  Children and Adults with ADHD , 4221 Forbes Blvd, Suite 270, Lanham, MD, 20706. Last retrieved on November 16, 2021 from: https://chadd.org/about-adhd/the-science-of-adhd/; Retreived on November 2021.
  4. Kooij JJS, Bijlenga D, Salerno L, et al. Updated European Consensus Statement on diagnosis and treatment of adult ADHD. European psychiatry. 2019;56:14-34.
  5. Harrington A. Mind fixers: Psychiatry's troubled search for the biology of mental illness. WW Norton & Company; 2019.
  6. Paulus MP, Thompson WK. The Challenges and Opportunities of Small Effects: The New Normal in Academic Psychiatry. JAMA Psychiatry. 2019;76(4):353-354. doi:10.1001/jamapsychiatry.2018.4540
  7. APA. Diagnostic and Statistical Manual of  Mental Disorders, 5th edition, Text Revision (DSM-5-TR). American Psychiatric Association.  Washington, DC; 2022.
  8. Engel GL. The need for a new medical model: a challenge for biomedicine. Science. 1977;196(4286):129-136.
  9. Lehman BJ, David DM, Gruber JA. Rethinking the biopsychosocial model of health: Understanding health as a dynamic system. https://doi.org/10.1111/spc3.12328. Social and Personality Psychology Compass. 2017/08/01 2017;11(8):e12328. doi:https://doi.org/10.1111/spc3.12328
  10. Belmaker RH, Lichtenberg P. Psychopharmacology Reconsidered: A Concise Guide Exploring the Limits of Diagnosis and Treatment. Springer; 2023.
  11. te Meerman S, Batstra L, Freedman JE, Hoekstra R, Grietens H. ADHD and brain anatomy: What do academic textbooks used in the Netherlands tell students? Children & society. 2020;34(2):136-150.
  12. Davidovitch M, Shmueli D, Rotem RS, Bloch AM. Diagnosis despite clinical ambiguity: physicians’ perspectives on the rise in Autism Spectrum disorder incidence. BMC Psychiatry. 2021/03/12 2021;21(1):150. doi:10.1186/s12888-021-03151-z
  13. Leark RA, Greenberg LM, Kindschi CL, Dupuy TR, Hughes SJ. Test of variables of attention continuous performance test. The TOVA Company. 2007;
  14. Berger I, Goldzweig G. Objective measures of attention-deficit/hyperactivity disorder: a pilot study. IMAJ-Israel Medical Association Journal. 2010;12(9):531.
  15. Barkley RA. Neuropsychological testing is not useful in the diagnosis of ADHD: Stop it (or prove it)! The ADHD Report. 2019;27(2):1-8.
  16. Bunge M. The mind–body problem: A psychobiological approach. Elsevier; 2014.
  17. Nostro AD, Müller VI, Varikuti DP, et al. Predicting personality from network-based resting-state functional connectivity. Brain Structure and Function. 2018;223(6):2699-2719.
  18. Hsu W-T, Rosenberg MD, Scheinost D, Constable RT, Chun MM. Resting-state functional connectivity predicts neuroticism and extraversion in novel individuals. Social cognitive and affective neuroscience. 2018;13(2):224-232.
  19. Ponseti J, Siebner HR, Klöppel S, et al. Homosexual women have less grey matter in perirhinal cortex than heterosexual women. PloS one. 2007;2(8):e762.
  20. Swaab DF. Sexual differentiation of the human brain: relevance for gender identity, transsexualism and sexual orientation. Gynecological Endocrinology. 2004;19(6):301-312.
  21. Drescher J. Out of DSM: Depathologizing Homosexuality. Behavioral sciences (Basel, Switzerland). 2015;5(4):565-575. doi:10.3390/bs5040565
  22. AACAP. ADHD & the Brain. The American Academy of Child and Adolescent Psychiatry (AACAP). Last retrieved on June 19, 2024 from: https://www.aacap.org/AACAP/Families_and_Youth/Facts_for_Families/FFF-Guide/ADHD_and_the_Brain-121.aspx; 2017.
  23. Norman LJ, Carlisi C, Lukito S, et al. Structural and functional brain abnormalities in attention-deficit/hyperactivity disorder and obsessive-compulsive disorder: a comparative meta-analysis. JAMA psychiatry. 2016;73(8):815-825.
  24. Hoogman M, Bralten J, Hibar DP, et al. Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: a cross-sectional mega-analysis. The Lancet Psychiatry. 2017;4(4):310-319.
  25. Hoogman M, Muetzel R, Guimaraes JP, et al. Brain imaging of the cortex in ADHD: a coordinated analysis of large-scale clinical and population-based samples. American Journal of Psychiatry. 2019:appi-ajp.
  26. Dehue T, Bijl D, de Winter M, et al. Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults. The Lancet Psychiatry. 2017;4(6):438-439. doi:10.1016/S2215-0366(17)30158-X
  27. Conners CK, Sitarenios G, Parker JDA, Epstein JN. The revised Conners' Parent Rating Scale (CPRS-R): factor structure, reliability, and criterion validity. Journal of abnormal child psychology. 1998;26(4):257-268.
  28. Leo J, Cohen D. Broken brains or flawed studies? A critical review of ADHD neuroimaging research. The Journal of mind and behavior. 2003:29-55.
  29. Samea F, Soluki S, Nejati V, et al. Brain alterations in children/adolescents with ADHD revisited: A neuroimaging meta-analysis of 96 structural and functional studies. Neuroscience & Biobehavioral Reviews. 2019;
  30. Elliott ML, Knodt AR, Ireland D, et al. What Is the Test-Retest Reliability of Common Task-Functional MRI Measures? New Empirical Evidence and a Meta-Analysis. Psychological Science. 2020/07/01 2020;31(7):792-806. doi:10.1177/0956797620916786
  31. Faraone SV, Banaschewski T, Coghill D, et al. The world federation of ADHD international consensus statement: 208 evidence-based conclusions about the disorder. Neuroscience & Biobehavioral Reviews. 2021;128:789-818.
  32. Bobb AJ, Castellanos FX, Addington AM, Rapoport JL. Molecular genetic studies of ADHD: 1991 to 2004. https://doi.org/10.1002/ajmg.b.30086. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2006/09/05 2006;141B(6):551-565. doi:https://doi.org/10.1002/ajmg.b.30086
  33. Faraone SV, Perlis RH, Doyle AE, et al. Molecular Genetics of Attention-Deficit/Hyperactivity Disorder. Biological Psychiatry. 2005/06/01/ 2005;57(11):1313-1323. doi:https://doi.org/10.1016/j.biopsych.2004.11.024
  34. APA. Diagnostic and Statistical Manual of Mental Disorders – Third Edition (DSM-III). American Psychiatric Association (APA); 1980.
  35. Ra CK, Cho J, Stone MD, et al. Association of Digital Media Use With Subsequent Symptoms of Attention-Deficit/Hyperactivity Disorder Among Adolescents. JAMA. 2018;320(3):255-263. doi:10.1001/jama.2018.8931
  36. Demontis D, Walters GB, Athanasiadis G, et al. Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains. Nature Genetics. 2023/01/26 2023;doi:10.1038/s41588-022-01285-8
  37. Curtis D. Analysis of 50,000 exome-sequenced UK Biobank subjects fails to identify genes influencing probability of developing a mood disorder resulting in psychiatric referral. Journal of Affective Disorders. 2021/02/15/ 2021;281:216-219. doi:https://doi.org/10.1016/j.jad.2020.12.025
  38. Whitaker R. Anatomy of an epidemic: Psychiatric drugs and the astonishing rise of mental illness in America. Ethical Human Psychology and Psychiatry. 2005;7(1):23.
  39. del Campo N, Chamberlain SR, Sahakian BJ, Robbins TW. The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder. Biological psychiatry. 2011;69(12):e145-e157.
  40. Mehta TR, Monegro A, Nene Y, Fayyaz M, Bollu PC. Neurobiology of ADHD: A review. Current Developmental Disorders Reports. 2019;6(4):235-240.
  41. Rosa-Neto P, Lou HC, Cumming P, et al. Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder. NeuroImage. 2005/04/15/ 2005;25(3):868-876. doi:https://doi.org/10.1016/j.neuroimage.2004.11.031
  42. NHS. Attention deficit hyperactivity disorder (ADHD) – Causes. The National Health Service (NHS) of Great Britain. Last retrieved on June 19, 2024 from: https://www.nhs.uk/conditions/attention-deficit-hyperactivity-disorder-adhd/causes/; 2021.
  43. עמותת קווים ומחשבות. מהי הפרעת קשב. קווים ומחשבות. העמותה הישראלית להפרעת קשב. נדלה לאחרונה בתאריך 10.8.23 מאתר: https://keshev.org/%d7%9e%d7%94%d7%99-%d7%94%d7%a4%d7%a8%d7%a2%d7%aa-%d7%a7%d7%a9%d7%91/; נדלה לאחרונה באוגוסט 2023.
  44. עמותת קווים ומחשבות. לאנשים עם הפרעת קשב ישנו מחסור והפחתה של דופמין. קווים ומחשבות – העמותה הישראלית להפרעת קשב. נדלה לאחרונה בתאריך 18.7.23 מפוסט שפורסם בדף הפייסבוק של העמותה:  https://www.facebook.com/100064542916070/posts/pfbid02mx2h2oUHVSz1fYHG7TEVcr7KqJ9YMPb34xhLNfTTT5YLnGqiXVCmm8DGgcFmdwXDl/?mibextid=5eVWNK; 2023.
  45. גלעד א. תוכנית רדיו  מתאריך 11.9.2022 . הציטוט הוא מדברי המראיין בתגובה לדבריה של המרואיינת גב' רותם פאר מייסדת עמותת לנפ"ש. גלי צה"ל. נדלה לאחרונה בתאריך 22.6.23 מ: https://drive.google.com/file/d/1Y8A1I7LuACVuZIqt-mgpDqWGY_RtP4hS/view?usp=sharing; 2022.
  46. נובורטיס ישראל. עלון לצרכן לפי תקנות הרוקחים של תרופת הריטלין. נובורטיס פארמה, בזל, שווייץ. עלון זה נבדק ואושר על-ידי משרד הבריאות בפברואר 2017.; 2017.
  47. Spencer TJ, Biederman J, Madras BK, et al. In vivo neuroreceptor imaging in attention-deficit/hyperactivity disorder: a focus on the dopamine transporter. Biological psychiatry. 2005;57(11):1293-1300.
  48. Vaidya CJ, Gabrieli JDE. Searching for a neurobiological signature of attention deficit hyperactivity disorder. Molecular psychiatry. 1999;4(3)
  49. Vaidya CJ, Austin G, Kirkorian G, et al. Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. Proceedings of the National Academy of Sciences. 1998;95(24):14494-14499.
  50. Partridge BJ, Bell SK, Lucke JC, Yeates S, Hall WD. Smart drugs “as common as coffee”: media hype about neuroenhancement. PloS one. 2011;6(11):e28416.
  51. Korn L, Hassan K, Fainshtein N, Yusov N, Davidovitch N. Non-Medical Use of Prescription Stimulants for Treatment of Attention Disorders by University Students: Characteristics and Associations. Medical science monitor: international medical journal of experimental and clinical research. 2019;25:3778.
  52. DuPont RL, Coleman JJ, Bucher RH, Wilford BB. Characteristics and motives of college students who engage in nonmedical use of methylphenidate. American Journal on Addictions. 2008;17(3):167-171.
  53. Babcock Q, Byrne T. Student perceptions of methylphenidate abuse at a public liberal arts college. Journal of American college health. 2000;49(3):143-145.
  54. Peterkin AL, Crone CC, Sheridan MJ, Wise TN. Cognitive Performance Enhancement: Misuse or Self-Treatment? Journal of Attention Disorders. 2011/05/01 2010;15(4):263-268. doi:10.1177/1087054710365980
  55. Pievsky MA, McGrath RE. Neurocognitive effects of methylphenidate in adults with attention-deficit/hyperactivity disorder: A meta-analysis. Neuroscience & Biobehavioral Reviews. 2018;90:447-455.
  56. Bishop C, Roehrs T, Rosenthal L, Roth T. Alerting effects of methylphenidate under basal and sleep-deprived conditions. Experimental and Clinical Psychopharmacology. 1997;5(4):344.
  57. Roehrs T, Johanson CE, Meixner R, Turner L, Roth T. Reinforcing and subjective effects of methylphenidate: dose and time in bed. Experimental and clinical psychopharmacology. 2004;12(3):180.
  58. Volkow ND, Wang G-J, Fowler JS, et al. Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain. American Journal of Psychiatry. 2004;161(7):1173-1180.
  59. Eisenberg L. Commentary with a historical perspective by a child psychiatrist: when "ADHD" was the "brain-damaged child". 2007;(1044-5463 (Print))
  60. Schwarz A. ADHD nation: Children, doctors, big pharma, and the making of an American epidemic. Simon and Schuster; 2017.
  61. Arnsten AFT. Stimulants: therapeutic actions in ADHD. Neuropsychopharmacology. 2006;31(11):2376-2383.
  62. Diller LH. The Ritalin wars continue. Western Journal of Medicine. 2000;173(6):366.
  63. Wang G-J, Volkow ND, Wigal T, et al. Long-term stimulant treatment affects brain dopamine transporter level in patients with attention deficit hyperactive disorder. PloS one. 2013;8(5)
  64. Harris G, Carey B. Researchers fail to reveal full drug pay. New York Times: New York Times, Last retrieved on August 26, 2021 from:  https://www.nytimes.com/2008/06/08/us/08conflict.html; 2008.
  65. Lenzer J. Review launched after Harvard psychiatrist failed to disclose industry funding. BMJ. 2008;336(7657):1327. doi:10.1136/bmj.39609.364688.DB
  66. Quansah E, Zetterström TSC. Chronic methylphenidate preferentially alters catecholamine protein targets in the parietal cortex and ventral striatum. Neurochemistry International. 2019/03/01/ 2019;124:193-199. doi:https://doi.org/10.1016/j.neuint.2019.01.016
  67. Pies RW. Debunking the two chemical imbalance myths, again. Psychiatric Times. 2019;36(8)
  68. Gøtzsche PC. Critical psychiatry textbook. 1 ed. Institute for Scientific Freedom. Institute for Scientific Freedom; 2022.
  69. Krishnan V, Nestler EJ. Linking Molecules to Mood: New Insight Into the Biology of Depression. American Journal of Psychiatry. 2010/11/01 2010;167(11):1305-1320. doi:10.1176/appi.ajp.2009.10030434
  70. Jucaite A, Nyberg S. Dopaminergic hypothesis of schizophrenia: a historical perspective. Targets and emerging therapies for schizophrenia. 2012:5-35.
  71. Breggin PR. Rational principles of psychopharmacology for therapists, healthcare providers and clients. Journal of Contemporary Psychotherapy. 2016;46(1):1-13.
  72. Healy D. Serotonin and depression. BMJ : British Medical Journal. 2015;350:h1771. doi:10.1136/bmj.h1771
  73. Winter NR, Blanke J, Leenings R, et al. A Systematic Evaluation of Machine Learning-based Biomarkers for Major Depressive Disorder across Modalities. medRxiv. 2023:2023.02.27.23286311. doi:10.1101/2023.02.27.23286311
  74. Breggin P. The Ritalin fact book: What your doctor won't tell you about ADHD and stimulant drugs. Da Capo Lifelong Books; 2009.
  75. Doroshow DB. Performing a cure for schizophrenia: insulin coma therapy on the wards. Journal of the history of medicine and allied sciences. 2007;62(2):213-243.
  76. Freudenthal R, Moncrieff J. ‘A landmark in psychiatric progress’? The role of evidence in the rise and fall of insulin coma therapy. History of Psychiatry. 2022/03/01 2021;33(1):65-78. doi:10.1177/0957154X211062538
  77. Parlatini V, Bellato A, Gabellone A, et al. A state-of-the-art overview of candidate diagnostic biomarkers for Attention-deficit/hyperactivity disorder (ADHD). Expert Review of Molecular Diagnostics. 2024/04/02 2024;24(4):259-271. doi:10.1080/14737159.2024.2333277
  78. Hyman SE. The diagnosis of mental disorders: the problem of reification. Annual review of clinical psychology. 2010;6:155-179.
  79. אופיר י. השערה בעין הסערה: המהפכה הביו-רפואית [הכושלת] בפסיכיאטריה עומדת בבסיס המשבר בבריאות הנפש. פסיכולוגיה עברית נדלה לאחרונה בתאריך 16724 מאתר: https://wwwhebpsynet/articlesasp?id=4733. 2024;
  80. Fried EI. Studying mental disorders as systems, not syndromes. PsyArXiv. 2021;doi:https://doi.org/10.31234/osf.io/k4mhv
  81. Hacking I. Making up people. Forms of desire. Routledge; 2013:69-88.
  82. Kendler KS. DSM disorders and their criteria: how should they inter-relate? Psychological Medicine. 2017;47(12):2054-2060. doi:10.1017/S0033291717000678
  83. Silberstein RB, Pipingas A, Farrow M, Levy F, Stough CK, Camfield DA. Brain functional connectivity abnormalities in attention‐deficit hyperactivity disorder. Brain and behavior. 2016;6(12):e00583.
  84. Silberstein RB, Pipingas A, Farrow M, Levy F, Stough CK. Dopaminergic modulation of default mode network brain functional connectivity in attention deficit hyperactivity disorder. Brain and Behavior. 2016;6(12):e00582.
  85. Castellanos FX, Proal E. Large-scale brain systems in ADHD: beyond the prefrontal–striatal model. Trends in cognitive sciences. 2012;16(1):17-26.
  86. Buckner RL, Andrews-Hanna JR, Schacter DL. The brain's default network: anatomy, function, and relevance to disease. 2008;
  87. Silberstein R, Camfield DA, Nield G, Stough C. Gender differences in parieto‐frontal brain functional connectivity correlates of creativity. Brain and behavior. 2019;9(2):e01196.
  88. Davis TO. Conceptualizing Psychiatric Disorders Using ‘Four D’s’ of Diagnoses. The Internet Journal of Psychiatry. 2009;1(1):1.

 

בחזרה לעמוד הראשי של רשימת המקורות של הספר, לחצו כאן. 

דילוג לתוכן